KunduRV, PattersonS. Dermatologic conditions in skin of color: part I. Special considerations for common skin disorders. Am Fam Physician, 2013; 87(12):850–856.
3.
AkhiyatS, CardwellL, SokumbiO.Why dermatology is the second least diverse specialty in medicine: how did we get here?. Clin Dermatol, 2020; 38(3):310–315. doi:.
4.
BaeG, QiuM, ReeseE, et al.Changes in sex and ethnic diversity in dermatology residents over multiple decades. JAMA Dermatol, 2016; 152(1):92–94. doi:.
5.
SanthoshL, BabikJM. Trends in racial and ethnic diversity in internal medicine subspecialty fellowships from 2006 to 2018. JAMA Netw Open, 2020; 3(2):e1920482. doi:.
6.
MylavarapuP, GuptaNE, GudiV, et al.Diversity within the most competitive internal medicine fellowships: examining trends from 2008 to 2018. J Gen Intern Med, 2020; 35(9):2537–2544. doi:.
PandyaAG, AlexisAF, BergerTG, et al.Increasing racial and ethnic diversity in dermatology: a call to action. J Am Acad Dermatol, 2016; 74(3):584–587. doi:.
10.
BrayJK, ClineA, McMichaelAJ, et al.Differences in healthcare barriers based on racial and/or ethnic background for patients with psoriasis. J Dermatol Treat, 2021; 32:590–594. doi:.
11.
MarrastLM, ZallmanL, WoolhandlerS, et al.Minority physicians' role in the care of underserved patients: diversifying the physician workforce may be key in addressing health disparities. JAMA Intern Med, 2014; 174(2):289–291. doi:.
12.
TripathiR, KnuselKD, EzaldeinHH, et al.Association of demographic and socioeconomic characteristics with differences in use of outpatient dermatology services in the United States. JAMA Dermatol, 2018; 154(11):1286–1291. doi:.
13.
TaylorSC.Meeting the unique dermatologic needs of black patients. JAMA Dermatol, 2019; 155(10):1109–1110. doi:.
14.
Gorbatenko-RothK, ProseN, KunduRV, et al.Assessment of Black patients' perception of their dermatology care. JAMA Dermatol, 2019; 155:1129–1134. doi:.
15.
MundluruSN, RamalingamND, TranHN. Addressing internal medicine residents' discomfort with basic dermatology in persons of color in the primary care clinic. Am J Med Qual, 2019; 34(5):513. doi:.
16.
McKeseyJ, BergerTG, LimHW, et al.Cultural competence for the 21st century dermatologist practicing in the United States. J Am Acad Dermatol, 2017; 77(6):1159–1169. doi:.
17.
ShaversVL, FaganP, JonesD, et al.The state of research on racial/ethnic discrimination in the receipt of health care. Am J Public Health, 2012; 102(5):953–966. doi:.
18.
SchoenbergE, WangJV, DuffyR, et al.Uncovering unconscious bias and health disparities in the practice of dermatology. Skinmed, 2019; 17(6):367–368.
19.
WilsonBN, MuraseJE, SliwkaD, et al.Bridging racial differences in the clinical encounter: how implicit bias and stereotype threat contribute to health care disparities in the dermatology clinic. Int J Womens Dermatol, 2021; 7:139–144.
20.
OkoyeGA, NewsomeA, McKayS, et al.Harvey | Udo Schumacher (Reviewing Editor). Health disparities in mycosis fungoides. Cogent Med, 2016; 3:1. doi:.
21.
McConnellAR, LeiboldJM. Relations among the implicit association test, discriminatory behavior, and explicit measures of racial attitudes. J Exp Soc Psychol, 2001; 37(5):435–442. doi:.
22.
MarcelinJR, SirajDS, VictorR, et al.The impact of unconscious bias in healthcare: how to recognize and mitigate it. J Infect Dis, 2019; 220(220,suppl 2):S62–S73. doi:.
OkekeCAV, PerryJD, SimmondsFC, et al.Clinical trials and skin of color: the example of hidradenitis suppurativa. Dermatology, 2021; 1–5. doi:. Epub ahead of print.
26.
CharrowA, XiaFD, JoyceC, et al.Diversity in dermatology clinical trials: a systematic review. JAMA Dermatol, 2017; 153(2):193–198. doi:.
27.
GargA, KirbyJS, LavianJ, et al.Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol, 2017; 153(8):760–764. doi:.
PriceKN, KraseJM, LohTY, et al.Racial and ethnic disparities in global atopic dermatitis clinical trials. Br J Dermatol, 2020; 183(2):378–380. doi:.
30.
BrunnerPM, Guttman-YasskyE. Racial differences in atopic dermatitis. Ann Allergy Asthma Immunol, 2019; 122(5):449–455. doi:.
31.
SilverbergJI, HanifinJ, SimpsonEL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol, 2013; 133(7):1752–1759. doi:.
32.
HiranoSA, MurraySB, HarveyVM. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009. Pediatr Dermatol, 2012; 29(6):749–755. doi:.
33.
HumesK, JonesN, RamirezR. Overview of Race and Hispanic Origin: 2010. Washington, DC: U.S. Census Bureau; 2011. (2010 Census Brief C2010BR-02). Available at: https://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf. Accessed June18, 2021.
34.
DickelH, TaylorJS, EveyP, et al.Comparison of patch test results with a standard series among white and black racial groups. Am J Contact Dermat, 2001; 12(2):77–82. doi:.
35.
DeleoVA, TaylorSC, BelsitoDV, et al.The effect of race and ethnicity on patch test results. J Am Acad Dermatol, 2002; 46(2,suppl understanding):S107–S112. doi:.
36.
YuSH, KhannaU, TaylorJS, et al.Patch testing in the African American population: a 10-year experience. Dermatitis, 2019; 30(4):277–278. doi:.
37.
DeleoVA, AlexisA, WarshawEM, et al.The association of race/ethnicity and patch test results: North American Contact Dermatitis Group, 1998–2006. Dermatitis, 2016; 27(5):288–292. doi:.
38.
GargA, VaibhavS, ZhanT, BrodB, GaspariA. Patterns of allergic contact dermatitis in African Americans and Caucasians in a major metropolitan area over a ten-year period. 2021. In: Proceedings of the American Contact Dermatitis Society 32nd Annual Meeting; March 17–18, 2021.
BrayJK, McMichaelAJ, HuangWW, et al.Publication rates on the topic of racial and ethnic diversity in dermatology versus other specialties. Dermatol Online J, 2020; 26(3):13030/qt094243gp.
41.
WilsonBN, SunM, AshbaughAG, et al.Assessment of skin of color and diversity and inclusion content of dermatologic published literature: an analysis and call to action. Int J Womens Dermatol, 2021; 7:391–397. doi:.
BerardescaE, MaibachHI. Contact dermatitis in blacks. Dermatol Clin, 1988; 6(3):363–368.
44.
AndersenKE, MaibachHI. Black and white human skin differences. J Am Acad Dermatol, 1979; 1(3):276–282. doi:.
45.
FisherAA.Contact dermatitis in black patients. Cutis, 1977; 20(3):303.
46.
HafnerMFS, RodriguesAC, LazzariniR. Allergic contact dermatitis to cosmetics: retrospective analysis of a population subjected to patch tests between 2004 and 2017. An Bras Dermatol, 2020; 95(6):696–701. doi:.
47.
DeKovenJG, SilverbergJI, WarshawEM, et al.North American Contact Dermatitis Group patch test results: 2017–2018. Dermatitis, 2021; 32(2):111–123. doi:.
48.
DeKovenJG, WarshawEM, ZugKA, et al.North American Contact Dermatitis Group patch test results: 2015–2016. Dermatitis, 2018; 29(6):297–309. doi:.
WangX, LiLF, ZhaoDY, et al.Prevalence and clinical features of atopic dermatitis in China. Biomed Res Int, 2016; 2016:2568301. doi:.
51.
DeckersIA, McLeanS, LinssenS, et al.Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PLoS One, 2012; 7(7):e39803. doi:.
52.
KaufmanBP, Guttman-YasskyE, AlexisAF. Atopic dermatitis in diverse racial and ethnic groups—variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol, 2018; 27(4):340–357. doi:.
53.
SilverbergJI, SimpsonEL. Associations of childhood eczema severity: a US population-based study. Dermatitis, 2014; 25(3):107–114. doi:.
54.
ShawTE, CurrieGP, KoudelkaCW, et al.Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol, 2011; 131(1):67–73. doi:.
LeeE, KimS, LeeJ, et al.Ethnic differences in objective and subjective skin irritation response: an international study. Skin Res Technol, 2014; 20(3):265–269. doi:.
57.
SunLD, XiaoFL, LiY, et al.Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet, 2011; 43(7):690–694. doi:.
58.
MargolisDJ, MitraN, WubbenhorstB, et al.Association of filaggrin loss-of-function variants with race in children with atopic dermatitis. JAMA Dermatol, 2019; 155(11):1269–1276. doi:.
59.
MargolisDJ, ApterAJ, GuptaJ, et al.The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort. J Allergy Clin Immunol, 2012; 130(4):912–917. doi:.
60.
AhnK, KimBE, KimJ, et al.Recent advances in atopic dermatitis. Curr Opin Immunol, 2020; 66:14–21. doi:.
61.
NomuraT, WuJ, KabashimaK, et al.Endophenotypic variations of atopic dermatitis by age, race, and ethnicity. J Allergy Clin Immunol Pract, 2020; 8(6):1840–1852. doi:.
62.
OwenJL, VakhariaPP, SilverbergJI. The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis. Am J Clin Dermatol, 2018; 19(3):293–302. doi:.
63.
ScottI, AtwaterAR, ReederM. Update on contact dermatitis and patch testing in patients with skin of color. Cutis, 2021; 108(1):10–12. doi:.
64.
TamazianS, OboiteM, TreatJR. Patch testing in skin of color: a brief report. Pediatr Dermatol, 2021; 38(4):952–953. doi:.
65.
GraysonC, HeathCR. Dupilumab improves atopic dermatitis and post-inflammatory hyperpigmentation in patient with skin of color. J Drugs Dermatol, 2020; 19(7):776–778. doi:.